Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 12

1.

Integrin CD11b activation drives anti-tumor innate immunity.

Schmid MC, Khan SQ, Kaneda MM, Pathria P, Shepard R, Louis TL, Anand S, Woo G, Leem C, Faridi MH, Geraghty T, Rajagopalan A, Gupta S, Ahmed M, Vazquez-Padron RI, Cheresh DA, Gupta V, Varner JA.

Nat Commun. 2018 Dec 19;9(1):5379. doi: 10.1038/s41467-018-07387-4.

2.

PI3Kγ Activates Integrin α4 and Promotes Immune Suppressive Myeloid Cell Polarization during Tumor Progression.

Foubert P, Kaneda MM, Varner JA.

Cancer Immunol Res. 2017 Nov;5(11):957-968. doi: 10.1158/2326-6066.CIR-17-0143. Epub 2017 Sep 28.

3.

Combination immunotherapy with TLR agonists and checkpoint inhibitors suppresses head and neck cancer.

Sato-Kaneko F, Yao S, Ahmadi A, Zhang SS, Hosoya T, Kaneda MM, Varner JA, Pu M, Messer KS, Guiducci C, Coffman RL, Kitaura K, Matsutani T, Suzuki R, Carson DA, Hayashi T, Cohen EE.

JCI Insight. 2017 Sep 21;2(18). pii: 93397. doi: 10.1172/jci.insight.93397. eCollection 2017 Sep 21.

4.

Corrigendum: PI3Kγ is a molecular switch that controls immune suppression.

Kaneda MM, Messer KS, Ralainirina N, Li H, Leem CJ, Gorjestani S, Woo G, Nguyen AV, Figueiredo CC, Foubert P, Schmid MC, Pink M, Winkler DG, Rausch M, Palombella VJ, Kutok J, McGovern K, Frazer KA, Wu X, Karin M, Sasik R, Cohen EE, Varner JA.

Nature. 2017 Feb 2;542(7639):124. doi: 10.1038/nature21026. Epub 2016 Dec 14. No abstract available.

PMID:
27974794
5.

PI3Kγ is a molecular switch that controls immune suppression.

Kaneda MM, Messer KS, Ralainirina N, Li H, Leem CJ, Gorjestani S, Woo G, Nguyen AV, Figueiredo CC, Foubert P, Schmid MC, Pink M, Winkler DG, Rausch M, Palombella VJ, Kutok J, McGovern K, Frazer KA, Wu X, Karin M, Sasik R, Cohen EE, Varner JA.

Nature. 2016 Nov 17;539(7629):437-442. doi: 10.1038/nature19834. Epub 2016 Sep 19. Erratum in: Nature. 2017 Feb 2;542(7639):124.

6.

Macrophage PI3Kγ Drives Pancreatic Ductal Adenocarcinoma Progression.

Kaneda MM, Cappello P, Nguyen AV, Ralainirina N, Hardamon CR, Foubert P, Schmid MC, Sun P, Mose E, Bouvet M, Lowy AM, Valasek MA, Sasik R, Novelli F, Hirsch E, Varner JA.

Cancer Discov. 2016 Aug;6(8):870-85. doi: 10.1158/2159-8290.CD-15-1346. Epub 2016 May 13.

7.

Bruton Tyrosine Kinase-Dependent Immune Cell Cross-talk Drives Pancreas Cancer.

Gunderson AJ, Kaneda MM, Tsujikawa T, Nguyen AV, Affara NI, Ruffell B, Gorjestani S, Liudahl SM, Truitt M, Olson P, Kim G, Hanahan D, Tempero MA, Sheppard B, Irving B, Chang BY, Varner JA, Coussens LM.

Cancer Discov. 2016 Mar;6(3):270-85. doi: 10.1158/2159-8290.CD-15-0827. Epub 2015 Dec 29. Erratum in: Cancer Discov. 2016 Jul;6(7):802.

8.

Mechanisms of nucleotide trafficking during siRNA delivery to endothelial cells using perfluorocarbon nanoemulsions.

Kaneda MM, Sasaki Y, Lanza GM, Milbrandt J, Wickline SA.

Biomaterials. 2010 Apr;31(11):3079-86. doi: 10.1016/j.biomaterials.2010.01.006. Epub 2010 Jan 25.

9.

Perfluorocarbon nanoemulsions for quantitative molecular imaging and targeted therapeutics.

Kaneda MM, Caruthers S, Lanza GM, Wickline SA.

Ann Biomed Eng. 2009 Oct;37(10):1922-33. doi: 10.1007/s10439-009-9643-z. Epub 2009 Jan 30. Review.

10.

Endothelial cell migration in human plasma is enhanced by a narrow range of added sphingosine 1-phosphate: implications for biomaterials design.

Alford SK, Kaneda MM, Wacker BK, Elbert DL.

J Biomed Mater Res A. 2009 Jan;88(1):205-12. doi: 10.1002/jbm.a.31885.

PMID:
18286622
11.

Delivery of sphingosine 1-phosphate from poly(ethylene glycol) hydrogels.

Wacker BK, Scott EA, Kaneda MM, Alford SK, Elbert DL.

Biomacromolecules. 2006 Apr;7(4):1335-43.

12.

Fluid shear stress modulates cell migration induced by sphingosine 1-phosphate and vascular endothelial growth factor.

Hughes SK, Wacker BK, Kaneda MM, Elbert DL.

Ann Biomed Eng. 2005 Aug;33(8):1003-14.

PMID:
16133909

Supplemental Content

Loading ...
Support Center